Oura, the maker of the Oura Ring, has agreed to buy Counsel Health, an AI-native primary care company, for $625 million in cash. The companies announced the deal on 10 November 2026 and expect it to close before the end of the calendar year, subject to customary closing conditions. The move takes Oura beyond tracking sleep, activity and readiness scores and into delivering care, with Counsel's medical AI and board-certified physicians working inside the Oura app.
What the Deal Covers
Under the agreement, Oura is acquiring Counsel Health for $625 million in cash, subject to purchase price adjustments. Counsel will keep serving its existing enterprise partners, including health plans, health systems, employers and consumer health organisations, with the aim of bringing its care model to patients beyond Oura's member base. Counsel founder and chief executive Dr Muthu Alagappan will join Oura as chief clinical AI officer, and TechCrunch reported, citing Bloomberg, that about 70 Counsel employees will move across with him.
"Oura helps members understand their physiology and, with Counsel, they can take action on their health across a range of needs, from quick questions and prescriptions to lab results, chronic care, and referrals," said Tom Hale, chief executive officer of Oura. The companies plan to build on their existing partnership across three areas of care: preventive care, acute care, and specialty and chronic care, including reproductive health, aging and cardiometabolic health.
How Counsel's Care Model Works
Members start by chatting with Counsel's medical AI, which draws on connected medical records, earlier interactions, evidence-based clinical guidelines and continuous biometric data from the ring. At any point in the chat, a patient can add a board-certified Counsel physician, who can provide a diagnosis, prescriptions and referrals where appropriate. Counsel's physicians work through a proprietary Clinician Cockpit, an interface that brings together a patient's medical record and long-term health trends to give context for each decision.
Behind the chat sits a clinical AI harness that calls on specialised agents for tasks such as medical history-taking, guideline retrieval, records review and emergency detection. Counsel says each agent is evaluated for performance, safety and quality, and improved using feedback from its physicians. Physicians stay in the loop for clinical decisions. The two companies have already been working together since June 2026, when Counsel's service appeared inside the Oura app.
The companies also shared early figures from that partnership. More than 90 percent of surveyed Oura members using Counsel said their Oura data helped them get better care, and members who saw a Counsel physician rated their care experience 4.6 out of 5. Both figures come from the companies themselves and describe surveyed members, not a controlled study.
The Numbers Behind the Deal
Oura announced the deal alongside record quarterly figures. For the quarter ended 30 September 2026, revenue grew 153 percent year over year to $533 million, and the company reported $87 million of adjusted EBITDA, a 16 percent margin. For fiscal year 2026, revenue was about $1.75 billion, up 92 percent, and Oura counts more than six million members. All of these figures are preliminary and unaudited, and may change as Oura completes its year-end close and audit.
The deal comes a few weeks after Oura postponed a planned initial public offering of up to $2.2 billion, citing uncertainty in the IPO market. Counsel is a much smaller company: it raised a $25 million Series A about a year ago, led by Andreessen Horowitz and GV, and PitchBook estimates its total funding at about $36 million. The $625 million price is therefore a large bet on what Counsel's care model can do with Oura's scale behind it.
Why This Matters for Healthcare Organizations
The clearest signal for clinics and health systems is the direction of travel. Wearable makers are moving from measuring health to acting on it, and the next step is a care service attached to the device. Patients may soon arrive at appointments with ring data in hand and a consultation, prescription or referral already started inside an app. That changes the first conversation, since the patient has already been triaged by an AI chat and, in some cases, a physician.
The enterprise channel matters more than the consumer app for most clinics. Counsel already serves health plans, health systems and employers, and Oura says that work will continue. A health system that already works with Counsel could see the same service reach more of its patients through Oura's member base. Questions of responsibility also come into focus as AI takes a larger role in care, and the American Medical Association's framework on who should answer when clinical AI causes harm is a useful reference for any organisation weighing a similar model. Google's Gemini for healthcare preview shows the same push from another direction, with a general AI platform being shaped for clinical use.
Some details were not in the announcement. It did not set out what a Counsel visit will cost inside the Oura app, or how member health data will be handled under the combined service. Clinics and health systems considering a partnership should ask for those answers before recommending the service to patients. If your clinic fields patient questions about new digital care options, a patient portal that handles intake, scheduling and messages gives patients a straightforward way to ask, and our look at how an AI medical receptionist handles after-hours calls shows how clinics manage the first contact.
Analysis: A Ring That Can Act, Not Just Measure
Oura is buying three things: a working clinical operation, a clinical AI team, and a route into enterprise healthcare. The ring already tells members what is happening in their bodies. Counsel adds the ability to do something about it, with a physician in the loop. That is the logic of the deal, and it is a sound one on paper.
The test will be practical. Can continuous biometric data actually help a physician make a better decision in a short chat, and can the handoff from AI guidance to human care stay clean when a case is urgent or complex? The price also sets a high bar: $625 million for a company that raised about $36 million only makes sense if the combined service reaches far beyond Oura's current members. The deal has not closed, and the financial figures behind it are unaudited, so the story is still at the announcement stage.
Sources and References
- Counsel Health, Oura to Acquire Counsel Health to Advance Personalized Care, 10 November 2026: https://www.counselhealth.com/newsroom/oura-to-acquire-counsel-health-advancing-vision-for-more-connected-personalized-healthcare
- Unite.AI, Oura Agrees to Acquire Counsel Health to Connect AI and Physician Care, 10 November 2026: https://www.unite.ai/oura-agrees-to-acquire-counsel-health-to-connect-ai-and-physician-care/
- TechCrunch, Oura to acquire AI-native primary care startup Counsel Health for $625M, 10 November 2026: https://techcrunch.com/2026/11/10/oura-to-acquire-ai-native-primary-care-startup-counsel-health-for-625m/
Reporting based on the sources above, accessed 13 November 2026. The Counsel Health announcement was read directly, and the Unite.AI and TechCrunch reports were read directly and cross-checked against it. The close timing follows the companies' announcement, not the end-of-2027 date that appeared in one early report. Med Clinic X did not conduct original reporting or interviews for this article. Corrections: contact us via https://medclinicx.com/contact